Lauren Pacek
banner
lrpacek.bsky.social
Lauren Pacek
@lrpacek.bsky.social
Assistant Prof at Rutgers Institute for Nicotine & Tobacco Studies | Epidemiologist, house plant enthusiast, gardener | Research interests: tob reg sci, medication adherence, vulnerable populations, dual/poly tobacco use | Opinions my own
You can't say "inclusion criteria," ffs 🤦🏻‍♀️
February 4, 2025 at 11:01 PM
Some variation based on study. In studies where only very low nic cigs were available, you see reductions in CPD, some increased quitting. This one (w/ noncombusted access) shows uptake of noncombusted products + fewer CPD and more smoke-free days (www.thelancet.com/journals/lan....
Reduced nicotine in cigarettes in a marketplace with alternative nicotine systems: randomized clinical trial
A reduced-nicotine cigarette standard in the context of access to other non-combusted nicotine products has the potential to benefit public health.
www.thelancet.com
December 13, 2024 at 9:16 PM
@sequencemyneuro.bsky.social happy to send links to articles, if interested!
December 13, 2024 at 8:15 PM
Clinical trials data show that if you reduce nicotine to a low enough level, it's essentially impossible to smoke enough cigs to get the amt of nicotine that smokers are looking for. You see initial compensatory smoking, but it doesn't last long and they give up on it, and then you see reductions.
December 13, 2024 at 8:14 PM